The quandary over Antiviral Therapy for a COVID-19 Patient with Glucose-6- Phosphate Dehydrogenase Deficiency, Hypertension, and Resolved Hepatitis B Infection: A Case Report

The quandary over Antiviral Therapy for a COVID-19 Patient with Glucose-6- Phosphate Dehydrogenase Deficiency, Hypertension, and Resolved Hepatitis B Infection: A Case Report

Coronavirus disease (COVID-19) pandemic has affected worldwide health care. Given the possibility for coronavirus to prompt oxidative stress, masked glucose-6-phosphate dehydrogenase deficiency (G6PD) deficiency in the presence of the COVID-19 viral infection may instigate hemolytic crisis and d...

Full description

Saved in:
Bibliographic Details
Main Authors: Prakash Gyandev Gondode1, Ankita Garg2, Satyajeet Sahoo3, Ankit Sharma4
Format: Article
Language:English
Published: Pasteur Institute of Iran 2021-12-01
Series:Journal of Medical Microbiology and Infectious Diseases
Subjects:
coronavirus
g6pd deficiency
hepatitis b
remdesivir
Online Access:https://jommid.pasteur.ac.ir/article-1-368-en.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jommid.pasteur.ac.ir/article-1-368-en.html

Similar Items